SOCIAL DETERMINANTS OF HEALTH ARE ASSOCIATED WITH OVERALL MORTALITY AND INCIDENCE OF CIRRHOSIS AND CARDIOVASCULAR DISEASE AMONG PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE

被引：0
|
作者：
Song, Michael W. [1 ]
Goyal, Tanvi [2 ]
Miller, Matthew [1 ]
Wijarnpreecha, Karn [3 ]
Chen, Vincent [4 ]
机构：
[1] Univ Michigan, Internal Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
[3] Univ Arizona, Coll Med, Gastroenterol & Hepatol, Phoenix, AZ USA
[4] Univ Michigan, Div Gastroenterol & Hepatol, Ann Arbor, MI 48109 USA
来源：
HEPATOLOGY | 2022年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
110
引用
收藏
页码：S100 / S100
页数：1
相关论文
共 50 条
  • [1] FERRITIN IS ASSOCIATED WITH INCREASED MORTALITY, PROGRESSION TO CIRRHOSIS, AND DEVELOPMENT OF CARDIOVASCULAR DISEASE IN METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE
    Suresh, Deepika
    Miller, Matthew
    Wijarnpreecha, Karn
    Chen, Vincent
    HEPATOLOGY, 2022, 76 : S714 - S715
  • [2] Incidence of Cirrhosis and Hepatocellular Carcinoma Among Veterans With Noncirrhotic Metabolic Dysfunction-associated Fatty Liver Disease
    Yeoh, Aaron
    Yang, Zeyuan
    Cheung, Ramsey
    Do, Albert
    Ahmed, Aijaz
    Wong, Robert J.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2024, 58 (07) : 718 - 725
  • [3] METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE AND RISK OF CARDIOVASCULAR DISEASE MORTALITY AMONG NON-HISPANIC BLACKS
    Dai, Wei
    Foster, Kristoff
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 708 - 708
  • [4] Metabolic Dysfunction-Associated Fatty Liver Disease, Statins, and Atherosclerotic Cardiovascular Disease
    Chang, Hui-Chin
    Gau, Shuo-Yan
    AMERICAN JOURNAL OF MEDICINE, 2024, 137 (01): : E14 - E14
  • [5] Metabolic Dysfunction-Associated Fatty Liver Disease Predicts Long-term Mortality and Cardiovascular Disease
    Moon, Joon Ho
    Kim, Won
    Koo, Bo Kyung
    Cho, Nam H.
    GUT AND LIVER, 2022, 16 (03) : 433 - 442
  • [6] From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
    Chen, Li
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (12) : 1253 - 1257
  • [7] Metabolic dysfunction-associated fatty liver disease and cardiovascular disease: A meta-analysis
    Wen, Wen
    Li, Hong
    Wang, Chunyi
    Chen, Chen
    Tang, Jiake
    Zhou, Mengyun
    Hong, Xuwei
    Cheng, Yongran
    Wu, Qi
    Zhang, Xingwei
    Feng, Zhanhui
    Wang, Mingwei
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [8] Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
    Xiao-Dong Zhou
    Jingjing Cai
    Giovanni Targher
    Christopher D. Byrne
    Michael D. Shapiro
    Ki-Chul Sung
    Virend K. Somers
    C. Anwar A. Chahal
    Jacob George
    Li-Li Chen
    Yong Zhou
    Ming-Hua Zheng
    Cardiovascular Diabetology, 21
  • [9] Associations between metabolic dysfunction-associated fatty liver disease and atherosclerotic cardiovascular disease
    Wen, Wen
    Fan, Hua
    Zhang, Shenghui
    Hu, Siqi
    Chen, Chen
    Tang, Jiake
    You, Yao
    Wang, Chunyi
    Li, Jie
    Luo, Lin
    Cheng, Yongran
    Zhou, Mengyun
    Zhao, Xuezhi
    Tan, Tao
    Xu, Fangfang
    Fu, Xinyan
    Chen, Juan
    Dong, Peng
    Zhang, Xingwei
    Wang, Mingwei
    Feng, Yan
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2024, 368 (06): : 557 - 568
  • [10] Metabolic Dysfunction-Associated Fatty Liver Disease Better Predicts Incident Cardiovascular Disease
    Jeong, Seogsong
    Oh, Yun Hwan
    Choi, Seulggie
    Chang, Jooyoung
    Kim, Sung Min
    Son, Joung Sik
    Lee, Gyeongsil
    Kim, Won
    Park, Sang Min
    GUT AND LIVER, 2021, : 589 - 598
12345